Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DepLIPIDO: HDL Analysis in Depression
NCT05099341Recruiting
- Sponsor
- Centre Hospitalier Universitaire Dijon Bourgogne
- Start
- Oct 2021
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
Open-label trial (3 arms), sponsored by Centre Hospitalier Universitaire Dijon Bourgogne. Primary endpoint: Cholesterol efflux capacity. Started Oct 2021; status: recruiting.
Beyond the preview
Go deeper on NCT05099341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05099341.